stockrowSanuwave Health Inc.
SNWV Healthcare Medical Devices
Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024.
- Revenue
- −3.13%
- EPS
- −224.2%
- Free cash flow
- +86.8%
- Total debt
- −28.4%
Quarter to June 2026, against a year earlier
Follow SNWV
Alert me
Sanuwave Health Inc. (SNWV) EV/Sales
As of 5 November 2026, Sanuwave Health Inc. (SNWV) trades at a EV/Sales of 0.7×. Over the past ten years it has ranged from 0.7× (November 2026) to 10.3× (August 2025) — the current reading is the lowest in ten years. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 6.0× | 67.02% |
| FY2024 | 3.6× | 66.39% |
| FY2023 | 2.2× | 0.00% |
| FY2022 | 2.2× | 0.00% |
| FY2021 | 2.2× | 0.00% |
| FY2020 | 2.2× | 0.00% |
| FY2019 | 2.2× | 0.00% |
| FY2018 | 2.2× | 0.00% |
| FY2017 | 2.2× | 0.00% |
| FY2016 | 2.2× | 0.00% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.2× | (39.05%) |
| Mar 2026 | 3.6× | (40.76%) |
| Dec 2025 | 6.0× | (25.93%) |
| Sep 2025 | 8.1× | 6.13% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| SNWV Sanuwave Health Inc. | 0.7× |
| CVRX CVRx, Inc. compare | 0.7× |
| TELA TELA Bio, Inc. compare | 1.0× |
| MYO Myomo, Inc. compare | 1.1× |
| SRTS Sensus Healthcare, Inc. compare | 2.2× |
| NSPR InspireMD, Inc. compare | 2.5× |
| MDAI Spectral AI, Inc. compare | 2.7× |
| COCH Envoy Medical, Inc. compare | 389× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)